文献速递中枢神经肿瘤放疗放疗物理与技术

原发性脑肿瘤放疗患者报告结局与辐射剂量的关联

Associations between patient-reported outcomes and radiation dose in patients treated with radiation therapy for primary brain tumours.
PubMed 文献 · Clin Transl Radiat Oncol · 2021-09-27

一项横断面研究纳入78例接受放疗的非胶质母细胞瘤原发性脑肿瘤患者,中位检测时间距放疗4.6年。研究发现全脑、脑干、海马等结构的高平均辐射剂量与较低的健康相关生活质量及自我报告认知功能评分相关,且自我报告认知功能与神经心理测试评分存在相关性。

要点

  • 全脑、脑干、海马高平均剂量与低HRQoL相关。
  • 全脑、脑干、海马、颞叶、丘脑高剂量与低自报认知功能相关。
  • 自报认知功能与神经心理测试评分相关(r=0.27-0.54)。

核心结论

  • 特定脑结构的高辐射剂量可能与患者HRQoL及自我报告认知功能受损相关,可能对日常生活产生负面影响。

研究设计与样本

  • 横断面研究,纳入78例接受放疗的非胶质母细胞瘤原发性脑肿瘤患者,进行神经心理测试并填写HRQoL、认知功能、疲劳、抑郁、焦虑及知觉压力问卷。

主要发现

  • 全脑高平均剂量与低HRQoL相关(Cohen's d=0.50,p=0.04),脑干(d=0.65,p=0.01)和海马(d=0.66,p=0.01)同样相关。
  • 全脑高平均剂量与低自报认知功能相关(d=0.64,p=0.02),脑干(d=0.55,p=0.03)、海马(d=0.76,p<0.01)、颞叶(d=0.70,p<0.01)和丘脑(d=0.64,p=0.01)也相关。
  • 自报认知功能与神经心理测试评分相关性良好(相关系数范围0.27-0.54)。
  • 放疗与检测的中位时间为4.6年(范围1-9年)。

临床怎么用

  • 在制定脑肿瘤放疗计划时,应关注全脑、脑干、海马、颞叶及丘脑的剂量,以可能保护HRQoL和认知功能。
  • 患者报告结局与剂量-结构关联可提供脑及亚结构辐射耐受性的重要信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: This study aimed to explore associations between radiation dose and patient-reported outcomes in patients with a primary non-glioblastoma brain tumour treated with radiation therapy (RT), with a focus on health-related quality-of-life (HRQoL) and self-reported cognitive function. METHODS: In this cross-sectional study, 78 patients who had received RT for a non-glioblastoma primary brain tumour, underwent neuropsychological testing and completed questionnaires on HRQoL, cognitive function, fatigue, depression, anxiety and perceived stress. The study explores the association between HRQoL scores, self-reported cognitive function and radiation doses to total brain, brainstem, hippocampus, thalamus, temporal lobes and frontal lobes. In addition, we examined correlations between neuropsychological test scores and self-reported cognitive function. RESULTS: The median time between RT and testing was 4.6 years (range 1-9 years). Patients who had received high mean radiation doses to the total brain had low HRQoL scores (Cohen's d = 0.50, p = 0.04), brainstem (d = 0.65, p = 0.01) and hippocampus (d = 0.66, p = 0.01). High mean doses to the total brain were also associated with low scores on self-reported cognitive functioning (Cohen's d = 0.64, p = 0.02), brainstem (d = 0.55, p = 0.03), hippocampus (d = 0.76, p < 0.01), temporal lobes (d = 0.70, p < 0.01) and thalamus (d = 0.64, p = 0.01). Self-reported cognitive function correlated well with neuropsychological test scores (correlation range 0.27-0.54.). CONCLUSIONS: High radiation doses to specific brain structures may be associated with impaired HRQoL and self-reported cognitive function with potentially negative implications to patients' daily lives. Patient-reported outcomes of treatment-related side-effects and their associations with radiation doses to the brain and its sub-structures may provide important information on radiation tolerance to the brain and sub-structures.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Haldbo-Classen L, Amidi A, Wu LM, et al. Associations between patient-reported outcomes and radiation dose in patients treated with radiation therapy for primary brain tumours. Clin Transl Radiat Oncol. 2021. PMID: 34693039. doi:10.1016/j.ctro.2021.09.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。